The NIHR Manchester BRC, in collaboration with the NIHR Manchester CRF and supported by Oxford Road Corridor and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it.
This workshop will provide attendees with opportunities to discuss and develop practical strategies for effective PPIE to enhance the design and delivery of their research and to meet the requirements of research funders.
A recent review of dementia prevention, intervention and care in the Lancet identified hearing impairment as the largest potentially modifiable mid-life risk factor for dementia. In response Dr Piers Dawes has written a blog post for policy@manchester
Three new publications in the high impact JAMA group of journals provide information that could shape the way in which patients with a genetic predisposition are screened for cancers associated with brain and nerve cell tumours, Lynch Syndrome and Li-Fraumeni Syndrome.
The BRC has been busy this summer conducting scoping work to inform an ambitious, five year patient and public involvement and engagement (PPIE) strategy. Delivering exemplary PPIE across Greater Manchester, the strategy will serve both the BRC and the NIHR Manchester CRF.
Dr Piers Dawes comments on the Lancet Commission on dementia prevention, intervention and care.
The NIHR Manchester BRC and CRF launch event on 6 June 2017 represented a double celebration. An opportunity to share our aspirations for BRC and CRF, and also to mark the first anniversary of the GMHSCP devolution of the city region’s £6bn health and social care budget.
In May Professor Kevin Munro attended the Phonak Paediatric Advisory Board in Nashville. Phonak is a leading international hearing device company with a particular interest in children with hearing loss.